Thrombophilic risk factors in patients with cranial and spinal dural arteriovenous fistulae

Neurosurgery

Volumn 63, Issue 4, 2008, Pages 693-698

  Gerlach, Rüediger ^a   Boehm Weigert, Martina ^a   Berkefeld, Joachim ^a   Duis, Judith ^a   Raabe, Andreas ^a   Seifert, Volker ^a   Marquardt, Gerhard ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Dural arteriovenous fistulae; Factor V mutation; Hemorrhage; Neurosurgical procedures; Prothrombin mutation; Sinus thrombosis; Venous hypertension

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; CARDIOLIPIN ANTIBODY; D DIMER; FIBRINOGEN; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN; RISTOCETIN; TISSUE FACTOR PATHWAY INHIBITOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; BLOOD SAMPLING; CEREBROVASCULAR MALFORMATION; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CRANIAL DURAL ARTERIOVENOUS FISTULA; DIGITAL SUBTRACTION ANGIOGRAPHY; ENZYME ACTIVITY; FEMALE; FISHER EXACT TEST; GENE MUTATION; GENETIC MARKER; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; SPINAL DURAL ARTERIOVENOUS FISTULA; THROMBOPHILIA;

ADULT; AGED; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS; COMORBIDITY; DURA MATER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MALE; MIDDLE AGED; MUTATION; PREVALENCE; RISK FACTORS; SPINE; THROMBOSIS;

EID: 56749183298     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000325730.77263.7E     Document Type: Article

References (49)

1. Bank I, Libourel EJ, Middeldorp S, Hamulyák K, van Pampus EC, Koopman MM, Prins MH, van der Meer J, Büller HR: Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis. J Thromb Haemost 3:79-84, 2005.
2. Britz GW, Lazar D, Eskridge J, Winn HR: Accurate intraoperative localization of spinal dural arteriovenous fistulae with embolization coil: Technical note. Neurosurgery 55:252-255, 2004.
3. Cenzato M, Versari P, Righi C, Simionato F, Casali C, Giovanelli M: Spinal dural arteriovenous fistulae: Analysis of outcome in relation to pretreatment indicators. Neurosurgery 55:815-823, 2004.
4. Chaudhary MY, Sachdev VP, Cho SH, Weitzner I Jr, Puljic S, Huang YP: Dural arteriovenous malformation of the major venous sinuses: An acquired lesion. AJNR Am J Neuroradiol 3:13-19, 1982.
5. Cognard C, Casasco A, Toevi M, Houdart E, Chiras J, Merland JJ: Dural arteriovenous fistulae as a cause of intracranial hypertension due to impairment of cranial venous outflow. J Neurol Neurosurg Psychiatry 65:308-316, 1998.
6. Cognard C, Gobin YP, Pierot L, Bailly AL, Houdart E, Casasco A, Chiras J, Merland JJ: Cerebral dural arteriovenous fistulae: Clinical and angiographic correlation with a revised classification of venous drainage. Radiology 194:671-680, 1995.
7. da Costa LB, TerBrugge K, Farb R, Wallace MC: Surgical disconnection of cortical venous reflux as a treatment for Borden type II dural arteriovenous fistulae. Acta Neurochir (Wien) 149:1103-1108, 2007.
8. Dahlbäck B: New molecular insights into the genetics of thrombophilia: Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis. Thromb Haemost 74:139-148, 1995.
9. De Stefano V, Chiusolo P, Paciaroni K, Leone G: Epidemiology of factor V Leiden: Clinical implications. Semin Thromb Hemost 24:367-379, 1998.
10. De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G: The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 341:801-806, 1999.
11. Deschiens MA, Conard J, Horellou MH, Ameri A, Preter M, Chedru F, Samama MM, Bousser MG: Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 27:1724-1730, 1996.
12. Finsterer J, Bavinzski G, Ungersböck K: Spinal dural arteriovenous fistula associated with syringomyelia. J Neuroradiol 27:211-214, 2000.
13. Gerlach R, Yahya H, Rohde S, Böhm M, Berkefeld J, Scharrer I, Seifert V, Raabe A: Increased incidence of thrombophilic abnormalities in patients with cranial dural arteriovenous fistulae. Neurol Res 25:745-748, 2003.
14. Herman JM, Spetzler RF, Bederson JB, Kurbat JM, Zabramski JM: Genesis of a dural arteriovenous malformation in a rat model. J Neurosurg 83:539-545, 1995.
15. Hillarp A, Zöller B, Svensson PJ, Dahlbäck B: The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 78:990-992, 1997.
16. Houser OW, Campbell JK, Campbell RJ, Sundt TM Jr: Arteriovenous malformation affecting the transverse dural venous sinus: An acquired lesion. Mayo Clin Proc 54:651-661, 1979.
17. Hudson M, Herr AL, Rauch J, Neville C, Chang E, Ibrahim R, Séguin C, Kassis J, Busque L, Fortin PR: The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies. J Rheumatol 30:2385-2391, 2003.
18. Irani-Hakime N, Tamim H, Elias G, Choueiry S, Kreidy R, Daccache JL, Almawi WY: Factor V R506Q mutation-Leiden: An independent risk factor for venous thrombosis but not coronary artery disease. J Thromb Thrombolysis 11:111-116, 2001.
19. Izumi T, Miyachi S, Hattori K, Iizuka H, Nakane Y, Yoshida J: Thrombophilic abnormalities among patients with cranial dural arteriovenous fistulae. Neurosurgery 61:262-269, 2007.
20. Jellema K, Tijssen CC, Fijnheer R, de Groot PG, Koudstaal PJ, van Gijn J: Spinal dural arteriovenous fistulae are not associated with prothrombotic factors. Stroke 35:2069-2071, 2004.
21. Kakarla UK, Deshmukh VR, Zabramski JM, Albuquerque FC, McDougall CG, Spetzler RF: Surgical treatment of high-risk intracranial dural arteriovenous fistulae: Clinical outcomes and avoidance of complications. Neurosurgery 61:447-459, 2007.
22. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342:1503-1506, 1993.
23. Kraus JA, Srüper BK, Berlit P: Association of resistance to activated protein C and dural arteriovenous fistulae. J Neurol 245:731-733, 1998.
24. Kraus JA, Srüper BK, Müller J, Nahser HC, Klockgether T, Berlit P, Harbrecht U: Molecular analysis of thrombophilic risk factors in patients with dural arteriovenous fistulae. J Neurol 249:680-682, 2002.
25. Kraus JA, Stüper BK, Nahser HC, Klockgether T, Berlit P: Significantly increased prevalence of factor V Leiden in patients with dural arteriovenous fistulae. J Neurol 247:521-523, 2000.
26. Lüdemann P, Nabavi DG, Junker R, Wolff E, Papke K, Buchner H, Assmann G, Ringelstein EB: Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: A case-control study of 55 patients. Stroke 29:2507-2510, 1998.
27. Mironov A: Classification of spontaneous dural arteriovenous fistulae with regard to their pathogenesis. Acta Radiol 36:582-592, 1995.
28. Mullan S: Reflections upon the nature and management of intracranial and intraspinal vascular malformations and fistulae. J Neurosurg 80:606-616, 1994.
29. Mullan S, Johnson DL: Combined sagittal and lateral sinus dural fistulae occlusion. J Neurosurg 82:159-165, 1995.
30. Narvid J, Hetts SW, Larsen D, Neuhaus J, Singh TP, McSwain H, Lawton MT, Dowd CF, Higashida RT, Halbach VV: Spinal dural arteriovenous fistulae: Clinical features and long-term results. Neurosurgery 62:159-167, 2008.
31. Neville C, Rauch J, Kassis J, Chang ER, Joseph L, Le Comte M, Fortin PR: Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies. Thromb Haemost 90:108-115, 2003.
32. Nishijima M, Takaku A, Endo S, Kuwayama N, Koizumi F, Sato H, Owada K: Etiological evaluation of dural arteriovenous malformations of the lateral and sigmoid sinuses based on histopathological examinations. J Neurosurg 76:600-606, 1992.
33. O'Donnell J, Laffan M: Elevated plasma factor VIII levels: A novel risk factor for venous thromboembolism. Clin Lab 47:1-6, 2001.
34. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703, 1996.
35. Rodeghiero F, Tosetto A: Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Ann Intern Med 130:643-650, 1999.
36. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH: Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 79:706-708, 1998.
37. Selvarajah E, Boet R, Laing A: Combined surgical and endovascular treatment of a posterior fossa dural arteriovenous fistula. J Clin Neurosci 12:723-725, 2005.
38. Singh V, Meyers PM, Halbach VH, Gress DR, Higashida RT, Dowd CF, Smith WS: Dural arteriovenous fistula associated with prothrombin gene mutation. J Neuroimaging 11:319-321, 2001.
39. Steinmetz MP, Chow MM, Krishnaney AA, Andrews-Hinders D, Benzel EC, Masaryk TJ, Mayberg MR, Rasmussen PA: Outcome after the treatment of spinal dural arteriovenous fistulae: A contemporary single-institution series and meta-analysis. Neurosurgery 55:77-88, 2004.
40. Svensson PJ, Dahlbäck B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517-522, 1994.
41. Tacconi L, Lopez Izquierdo BC, Symon L: Outcome and prognostic factors in the surgical treatment of spinal dural arteriovenous fistulae. A long-term study. Br J Neurosurg 11:298-305, 1997.
42. Terada T, Higashida RT, Halbach VV, Dowd CF, Tsuura M, Komai N, Wilson CB, Hieshima GB: Development of acquired arteriovenous fistulae in rats due to venous hypertension. J Neurosurg 80:884-889, 1994.
43. Uranishi R, Nakase H, Sakaki T: Expression of angiogenic growth factors in dural arteriovenous fistula. J Neurosurg 91:781-786, 1999.
44. Van Dijk JM, TerBrugge KG, Van der Meer FJ, Wallace MC, Rosendaal FR: Thrombophilic factors and the formation of dural arteriovenous fistulae. J Neurosurg 107:56-59, 2007.
45. Van Dijk JM, TerBrugge KG, Willinsky RA, Farb RI, Wallace MC: Multidisciplinary management of spinal dural arteriovenous fistulae: Clinical presentation and long-term follow-up in 49 patients. Stroke 33:1578-1583, 2002.
46. Van Dijk JM, TerBrugge KG, Willinsky RA, Wallace MC: Clinical course of cranial dural arteriovenous fistulae with long-term persistent cortical venous reflux. Stroke 33:1233-1236, 2002.
47. Witt O, Pereira PL, Tillmann W: Severe cerebral venous sinus thrombosis and dural arteriovenous fistula in an infant with protein S deficiency. Childs Nerv Syst 15:128-130, 1999.
48. Zalavras ChG, Giotopoulou S, Dokou E, Mitsis M, Ioannou HV, Tsaousi C, Tzolou A, Kolaitis N, Vartholomatos G: Prevalence of the G20210A prothrombin gene mutation in Northwestern Greece and association with venous thromboembolism. Int Angiol 22:55-57, 2003.
49. Zöller B, Svensson PJ, He X, Dahlbäck B: Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 94:2521-2524, 1994.